Galileo Research Facts No. 172: Can Galileo Therapy increase Muscle Function in Interstitial Lung Diseases (ILD)?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 172: Can Galileo Therapy increase Muscle Function in Interstitial Lung Diseases (ILD)?

Posted by
This study investigated the effects of Galileo Therapy on muscle function (6MTW, CRT) in Interstitial Lung Diseases (ILD) (Age: 49-75). Galileo group: 30° squat, 3x3min, 26Hz, pos. 2-3, 16 weeks, 3/week, Control: identical exercises without Galileo. The Galileo group showed significant improvements in muscle function in 6MWT (+6%) and CRT (+13%) and at the same time an decrease in the inflammation parameter IL-6 (-33%)...
Continue reading
Galileo Research Facts No. 106: Can 8 weeks of Galileo Therapy decrease inflammation markers?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 106: Can 8 weeks of Galileo Therapy decrease inflammation markers?

Posted by
This case study reported the results of Galileo Therapy in a patient with Anti-Jo-1-Syndrome (auto-immune disease) on inflammation markers like CK, IL-8 and TNF-alpha (26Hz, pos. 2, 6*2 min. + 12 Hz, 3min. cool-down, week, 2 months). Additional therapy was not changed during this time. The results show a significant decrease of the inflammation makers CK, IL-8 and TNF-alpha after 8 weeks by up to 61%...
Continue reading